These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11240615)

  • 21. Gene therapy for hemophilia: past, present and future.
    George LA; Fogarty PF
    Semin Hematol; 2016 Jan; 53(1):46-54. PubMed ID: 26805907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to discuss gene therapy for haemophilia? A patient and physician perspective.
    Miesbach W; O'Mahony B; Key NS; Makris M
    Haemophilia; 2019 Jul; 25(4):545-557. PubMed ID: 31115117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in Gene Therapy for Hemophilia.
    Nathwani AC; Davidoff AM; Tuddenham EGD
    Hum Gene Ther; 2017 Nov; 28(11):1004-1012. PubMed ID: 28835123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic engineering for haemophilia A.
    Gan SU; Kon OL; Calne RY
    Expert Opin Biol Ther; 2006 Oct; 6(10):1023-30. PubMed ID: 16989584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.
    Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ
    Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Therapy for Hemophilia and Duchenne Muscular Dystrophy in China.
    Liu X; Liu M; Wu L; Liang D
    Hum Gene Ther; 2018 Feb; 29(2):146-150. PubMed ID: 29366352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy trials in the UK: is haemophilia a suitable 'model'?
    Uk Haemophilia Centre Doctors' Organisation Working Party
    Clin Med (Lond); 2004; 4(1):54-6. PubMed ID: 14998268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishing the appropriate primary endpoint in haemophilia gene therapy pivotal studies.
    Pierce GF; Ragni MV; van den Berg HM; Weill A; O'Mahony B; Skinner MW; Pipe SW
    Haemophilia; 2017 Sep; 23(5):643-644. PubMed ID: 28833947
    [No Abstract]   [Full Text] [Related]  

  • 29. Haemophilias: advances towards genetic engineering replacement therapy.
    Emilien G; Maloteaux JM; Penasse C; Goodeve A; Casimir C
    Clin Lab Haematol; 2000 Dec; 22(6):313-23. PubMed ID: 11318796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AAV-mediated gene therapy for hemophilia.
    Couto LB; Pierce GF
    Curr Opin Mol Ther; 2003 Oct; 5(5):517-23. PubMed ID: 14601521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gene therapy journey for hemophilia: are we there yet?
    High KA
    Hematology Am Soc Hematol Educ Program; 2012; 2012():375-81. PubMed ID: 23233607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene transfer for hemophilia: can therapeutic efficacy in large animals be safely translated to patients?
    High K
    J Thromb Haemost; 2005 Aug; 3(8):1682-91. PubMed ID: 16102034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems and prospects in gene therapy for hemophilia.
    Herzog RW; High KA
    Curr Opin Hematol; 1998 Sep; 5(5):321-6. PubMed ID: 9776210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State of the art: gene therapy of haemophilia.
    Spencer HT; Riley BE; Doering CB
    Haemophilia; 2016 Jul; 22 Suppl 5():66-71. PubMed ID: 27405679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical and clinical gene therapy for haemophilia.
    Chuah MK; Collen D; Vandendriessche T
    Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of gene therapy for hemophilia: current states and future perspectives].
    Ohmori T
    Rinsho Ketsueki; 2018; 59(10):2238-2246. PubMed ID: 30305531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy for hemophilia.
    Lynch CM
    Curr Opin Mol Ther; 1999 Aug; 1(4):493-9. PubMed ID: 11713765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
    Manno CS; Pierce GF; Arruda VR; Glader B; Ragni M; Rasko JJ; Ozelo MC; Hoots K; Blatt P; Konkle B; Dake M; Kaye R; Razavi M; Zajko A; Zehnder J; Rustagi PK; Nakai H; Chew A; Leonard D; Wright JF; Lessard RR; Sommer JM; Tigges M; Sabatino D; Luk A; Jiang H; Mingozzi F; Couto L; Ertl HC; High KA; Kay MA
    Nat Med; 2006 Mar; 12(3):342-7. PubMed ID: 16474400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What´s new in Gene Therapy of Hemophilia.
    Rodriguez-Merchan EC
    Curr Gene Ther; 2018; 18(2):107-114. PubMed ID: 29446741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy for hemophilia.
    Chuah MK; Evens H; VandenDriessche T
    J Thromb Haemost; 2013 Jun; 11 Suppl 1():99-110. PubMed ID: 23809114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.